Generation Bio Co (NASDAQ: GBIO) kicked off on Friday, down -6.37% from the previous trading day, before settling in for the closing price of $0.46. Over the past 52 weeks, GBIO has traded in a range of $0.44-$4.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 47.38%. While this was happening, its average annual earnings per share was recorded 43.69%. With a float of $45.80 million, this company’s outstanding shares have now reached $66.97 million.
Considering the fact that the conglomerate employs 115 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 87.06%, operating margin of -420.03%, and the pretax margin is -661.91%.
Generation Bio Co (GBIO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Generation Bio Co is 31.65%, while institutional ownership is 63.75%. The most recent insider transaction that took place on Jan 10 ’25, was worth 120,759. In this transaction Director of this company bought 125,791 shares at a rate of $0.96, taking the stock ownership to the 214,286 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director bought 85,000 for $0.97, making the entire transaction worth $82,450. This insider now owns 299,286 shares in total.
Generation Bio Co (GBIO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.87% during the next five years compared to -8.30% drop over the previous five years of trading.
Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators
Take a look at Generation Bio Co’s (GBIO) current performance indicators. Last quarter, stock had a quick ratio of 5.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.98, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.97 in one year’s time.
Technical Analysis of Generation Bio Co (GBIO)
Compared to the last year’s volume of 0.51 million, its volume of 0.39 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 7.69%. Additionally, its Average True Range was 0.06.
During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 0.72%, which indicates a significant decrease from 8.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.46% in the past 14 days, which was lower than the 75.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6556, while its 200-day Moving Average is $1.8140. Nevertheless, the first resistance level for the watch stands at $0.4562 in the near term. At $0.4846, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5066. If the price goes on to break the first support level at $0.4058, it is likely to go to the next support level at $0.3838. Now, if the price goes above the second support level, the third support stands at $0.3554.
Generation Bio Co (NASDAQ: GBIO) Key Stats
The company with the Market Capitalisation of 28.67 million has total of 67,008K Shares Outstanding. Its annual sales at the moment are 19,890 K in contrast with the sum of -131,670 K annual income. Company’s last quarter sales were recorded 4,190 K and last quarter income was -21,380 K.
